Male Infertility Diagnosis and Treatment Market
Global Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests, and Others) By Treatment (Drugs, ART Therapy, and Surgery) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global male infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 4% during the forecast period. Infertility in men occurs due to a deficiency in sperm formation. Infertility can have several causes and may rely on genetics, fitness, diseases, general health, and dietary contaminants. Some crucial causes of male infertility may include abnormal production or functioning of sperms owing to diabetes, HIV, gonorrhea, among others, and damage associated with cancer and its treatment. Additionally, problems with sperm delivery owing to certain genetic diseases, such as cystic fibrosis, damage or injury to the reproductive system, and blockage in the testicle are also the major causes of male infertility.
The major factors contributing to the growth of the global male infertility diagnosis and treatment market include a significant rise in the prevalence of infertility and considerable advances in the area of infertility. A significant rise in male infertility has been witnessed over the years. This may occur due to unhealthy lifestyle risk factors, such as psychological stress, alcohol, and caffeine consumption, cigarette smoking and obesity, and medical history. As per the US Department of Health and Human Services (HHS), out of 100 couples in the US, 12 to 13 have trouble conceiving. Nearly one-third of infertility cases are resulted due to fertility problems in men and another one-third of fertility problems are due to fertility problems in women.
Impact of COVID-19 Pandemic on Global Male Infertility Diagnosis and Treatment Market
COVID-19 has driven up healthcare expenditures, altered healthcare supply networks, and lowered non-covid footfall and test numbers dramatically. Due to the pandemic's quick onset uncertainty plagued the business, worsening the ongoing economic crisis. Footfall and test volumes dropped by 70-80% as a result of the viral outbreak. Fear of contracting the virus from healthcare workers or other patients has led to a dramatic decline in in-person visits over the last two years. The pandemic reaction takes precedence over the needs of 'non-Covid' patients. For those with infectious diseases and chronic illnesses, even basic check-ups become stressful and costly.
Segmental Outlook
The global male infertility diagnosis and treatment market is segmented based on diagnostic tests and treatment. Based on diagnostic tests, the market is classified into semen analysis, urinalysis, genetic testing, testicular biopsy, hormonal tests, and others. Based on treatment, the market is segmented into drugs, ART therapy, and surgery.
Global Male Infertility Diagnosis and Treatment Market Share by Diagnostic Tests, 2021 (%)
The Semen Analysis Sub-Segment is Anticipated to Hold Prominent Share in the Global Male Infertility Diagnosis and Treatment Market
Semen analysis is the most suitable and fundamental test with higher sensitivity that supports to detection of the condition among men suffering from the problem of male infertility. It is a test that evaluates sperm formation and maturity as well as the sperm interaction in the seminal fluid. It can accurately measure the number of sperm, their morphology (size and shape), their motility (ability to move), and the consistency and volume of the ejaculated sample. Normal sperm count ranges from 20 million to 200 million per milliliter. Semen analysis test enables the diagnosis of low sperm count and therefore, it has a major role to diagnose male infertility.
Regional Outlooks
The global male infertility diagnosis and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the North American regional market is expected to cater to considerable growth during the forecast period, owing to the steady increase in the infertility rates among men and the rising demand for assisted reproductive techniques (ART) therapy are contributing to the growth of the market.
Global Male Infertility Diagnosis and Treatment Market Growth, by Region 2022-2028
The Asia-Pacific Region is Expected to Hold a Prominent Share in the Global Male Infertility Diagnosis and Treatment Market
The Asia-Pacific region is expected to hold a prominent share in the global male infertility diagnosis and treatment market owing to Significant incidences of infertility coupled with initiatives to promote awareness for diagnosis and treatment of the condition is contributing to the growth of the market in the region. For instance, according to the World Health Organization (WHO) estimates, the overall prevalence of primary infertility in India is between 3.9% to 16.8%. In Indian states, the prevalence of infertility ranges from 3.7% in Uttar Pradesh, Himachal Pradesh, and Maharashtra, to 5% in Andhra Pradesh, and 15% in Kashmir. Male infertility is the cause of a couple's failure to conceive in a significant number of cases.
Market Players Outlook
The major companies serving the global male infertility diagnosis and treatment market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB, and Medical Electronic Systems. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2019, Merck Foundation launched the song “Life is Bigger” to raise awareness about male infertility in Africa and the Rest of the World. It is a part of a community awareness program which is referred to as Merck More than a Mother. This rising awareness initiative is supporting to create awareness among people, thereby increasing demand for male infertility diagnostic tests and treatment options.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Male Infertility Diagnosis and Treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Male Infertility Diagnosis and Treatment Market
- Recovery Scenario of Global Male Infertility Diagnosis and Treatment Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Male Infertility Diagnosis and Treatment Market by Diagnostic Tests
4.1.1.Semen Analysis
4.1.2.Urinalysis
4.1.3.Genetic Testing
4.1.4.Testicular Biopsy
4.1.5.Hormonal Tests
4.1.6.Others
4.2.Global Male Infertility Diagnosis and Treatment Market by Treatment
4.2.1.Drugs
4.2.2.Anti-Retroviral Therapy (ART)
4.2.3.Surgery
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Androvia LifeSciences
6.2.ASKA Pharmaceutical Co., Ltd.
6.3.Aytu BioScience, Inc.
6.4.Bayer AG
6.5.Bristol-Myers Squibb Co.
6.6.Cadila Pharmaceuticals Ltd.
6.7.Centogene AG
6.8.Cook Medical, Inc.
6.9.CooperSurgical Fertility & Genomic Solutions
6.10.Eli Lilly and Co.
6.11.FUJIFILM Irvine Scientific
6.12.Halotech DNA SL
6.13.Intas Pharmaceuticals Ltd.
6.14.Merck KGaA
6.15.PerkinElmer, Inc.
6.16.Pfizer, Inc.
6.17.Sanofi S.A.
6.18.SCSA Diagnostics, Inc.
6.19.Vitrolife AB
1.GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
2.GLOBAL SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL URINALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL HORMONAL TESTS MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL OTHER MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
9.GLOBAL DRUGS FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBAL ART FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL SURGERY FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13.NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14.NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
15.NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
16.EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17.EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
18.EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
19.ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20.ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
21.ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
22.REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23.REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
24.REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2022-2028 (%)
4.GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSTIC TESTS, 2021 VS 2028 (%)
5.GLOBAL SEMEN ANALYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL URINALYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL GENETIC TESTING MICROWAVE ABLATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL TESTICULAR BIOPSY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL HORMONAL TESTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
12.GLOBAL DRUGS FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL ART FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL SURGERY FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.US MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
16.CANADA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
17.UK MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
18.FRANCE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
19.GERMANY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
20.ITALY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
21.SPAIN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
22.REST OF EUROPE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
23.INDIA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
24.CHINA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
25.JAPAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
26.SOUTH KOREA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
27.REST OF ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
28.REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
